Financials

News Ideas Technicals

200230 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to TELCON RF PHARM operating, investing, and financing activities

200230 free cash flow for Q4 23 is -194.53 M KRW. For 2023, 200230 free cash flow was -3.01 B KRW and operating cash flow was -1.13 B KRW.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—